Stock listing

NASDAQ:PRDS Pardes Biosciences Inc Stock

Follow Pardes Biosciences Inc into a list and get an email when it puts out news.

Last close · NASDAQ:PRDS

$2.16 USD

Close on Sep 8, 2023 · No longer trades

Feb 17, 2021 to last close -80.0% · weekly closes, Feb 17, 2021 – Sep 8, 2023
Lowest – highest close
$0.85 – $17.02 USDSince Feb 17, 2021 · lowest Nov 29, 2022 · highest Dec 30, 2021

Delisted NASDAQ:PRDS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:PRDS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Owen Hughes
Other companies: AnaptysBio, Inc. (Member of the Audit Committee · Since at least May 11, 2026); XOMA Royalty Corporation (Chief Executive Officer, Director · Since at least Nov 11, 2024); C4 Therapeutics, Inc. (Director · Since at least Nov 16, 2023); ImageneBio, Inc. (Director · Dec 14, 2022 – Jun 7, 2024 · Past); Cullinan Therapeutics, Inc. (President and CEO, Director · Jan 7, 2021 – Jan 12, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Sep 14, 2021 · Past); Radius Health, Inc. (Director · Apr 23, 2013 – Aug 15, 2022 · Past)
Director · Feb 16, 2021 – Dec 23, 2021 · Past
Thomas Wiggans
Other companies: Pacira BioSciences, Inc. (Director · Since at least Jun 9, 2026); Jasper Therapeutics, Inc. (Chairman of the Board · Since at least Nov 1, 2023); Annexon, Inc. (Director · Since at least Jul 23, 2020); Forma Therapeutics Holdings Inc (Director · Sep 7, 2020 – Oct 14, 2022 · Past); Somaxon Pharmaceuticals Inc (Director · Jun 11, 2008 – Jul 2, 2012 · Past); Sangamo Therapeutics, Inc. (Director · Jun 4, 2008 – Jun 1, 2011 · Past); Onyx Pharmaceuticals Inc (Director · Aug 29, 2007 – Oct 1, 2013 · Past)
Chief Executive Officer, Director · Mar 1, 2022 – Aug 31, 2023 · Past
Heidi Henson
Other companies: Perspective Therapeutics, Inc. (Director · Since at least Jun 1, 2023); Lisata Therapeutics, Inc. (Director · Since at least Sep 15, 2022); PepGen Inc. (Non-Executive Director · Since at least May 5, 2022); Kura Oncology, Inc. (Chief Financial Officer · Mar 6, 2015 – Jan 24, 2018 · Past)
Chief Financial Officer · Dec 23, 2021 – Aug 31, 2023 · Past
Deborah M Autor
Other companies: Hims & Hers Health, Inc. (Chief Policy Officer, Director · Since at least Nov 15, 2024); Amneal Pharmaceuticals, Inc. (Director · Since at least Jul 29, 2022)
Director · Dec 23, 2021 – Aug 31, 2023 · Past
Lee D Arnold
Other companies: Aethlon Medical, Inc. (Chief Scientific Officer · Feb 1, 2023 – Feb 1, 2023 · Past); Assembly Biosciences, Inc. (Chief Scientific Officer · Jul 11, 2014 – Jul 11, 2014 · Past)
Chief Scientific Officer · Dec 23, 2021 – Feb 1, 2022 · Past
Michael Varney
Other companies: Erasca, Inc. (Chair of R&D, SAB Member and Board Director · Since at least Jul 15, 2021); Foundation Medicine Inc (Director · Apr 7, 2015 – Apr 7, 2015 · Past)
Director · Dec 23, 2021 – Aug 31, 2023 · Past
Alisa Michelle Mall
Other companies: JBG Smith Properties (Director · Since at least Apr 30, 2020)
Director · Feb 16, 2021 – Feb 16, 2021 · Past
Brian Philippe Tinmouth
Other companies: Scynexis, Inc. (Director · Since at least Jun 17, 2022)
Chief Bus. & Strategy Officer · Sep 14, 2022 – Sep 14, 2022 · Past
Daniel Dubin
Other companies: Disc Medicine, Inc. (Director · Aug 11, 2020 – Aug 11, 2020 · Past)
Director · Feb 16, 2021 – Dec 23, 2021 · Past
Dennis D Ryan
Other companies: Disc Medicine, Inc. (Chief Financial Officer · Aug 11, 2020 – Aug 11, 2020 · Past)
Chief Financial Officer · Feb 16, 2021 – Feb 16, 2021 · Past
All 13 people
PersonSeat
J. Jay Lobell
Other companies: Fortress Biotech, Inc. (Director · Since at least Sep 13, 2011)
Director · Dec 23, 2021 – Aug 31, 2023 · Past
Mark Auerbach
Other companies: Assembly Biosciences, Inc. (Director · May 30, 2018 – May 17, 2019 · Past)
Director · Dec 23, 2021 – Aug 31, 2023 · Past
Sean Brusky
Other companies: Prelude Therapeutics Incorporated (Chief Business Officer · Since at least Mar 5, 2026)
Chief Commercial Officer · Dec 23, 2021 – Feb 1, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Pardes Biosciences Inc.